Skip to content

Distress and Quality of Life During the Diagnostic Phase of a Suspected Serious Lung Disease

How Burdensome is the Diagnostic Phase ? Distress and Quality of Life in Patients Suspected of Having a (Serious) Lung Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02060877
Acronym
DIADISS
Enrollment
105
Registered
2014-02-12
Start date
2014-02-28
Completion date
2016-03-31
Last updated
2016-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suspected Lung Cancer

Keywords

suspected lung cancer, diagnostic work-up

Brief summary

The purpose of this study is to gain insight in the distress experience and quality of life of patients suspected of having a serious lung disease during the diagnostic phase and the period between diagnosis and start of treatment

Detailed description

A life-threatening disease often leads to distress, an emotional experience that can interfere with coping. Studies in lung cancer patients show high prevalence of distress during the course of the disease. However until now, very few research was done during the diagnostic workup. This prospective study will describe and explore distress, quality of life and illness perception in lung cancer patients during the diagnostic period until first follow-up visit 4 weeks after start of therapy. Patient reported questionnaires will be used.

Interventions

OTHERobservational study: use of patient questionnaires

observational study, there is no study intervention, only patient questionnaires

Sponsors

End-of-Life Research Group
CollaboratorOTHER
Universiteit Antwerpen
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ambulatory patient * imaging suggestive of lung cancer * written informed consent * able to complete questionnaires

Exclusion criteria

* solitary pulmonary nodule * previous diagnosis of cancer

Design outcomes

Primary

MeasureTime frameDescription
duration of diagnostic phase and period between diagnosis and treatment startdate of suspected lung cancer, date communication of diagnosis, date of treatment start
longitudinal assessment of distressat time of suspected lung cancer, at time of diagnosis, at time of treatment start, 4 weeks after treatment startpatient reported questionnaire (distress barometer)
longitudinal assessment of quality of lifeat time of suspected lung cancer, at time of diagnosis, at time of treatment start, 4 weeks after treatment startpatient reported questionnaire (EORTC QLQ-C30 + lung cancer module)
longitudinal assessment of illness perceptionat time of suspected lung cancer, at time of diagnosis, at time of treatment start, 4 weeks after treatment startpatient reported questionnaire (Brief-Illness Perception questionnaire)

Secondary

MeasureTime frameDescription
explore which factors are associated with distress, quality of life and illness perceptionfirst visit suspected lung cancer, communication of diagnosis, treatment start, 4 weeks after treatment startpotential associated factors include patient demographic characteristics, performed diagnostic procedures, disease and treatment characteristics

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026